A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Ethereum Software Infrastructure Provider Flashbots Raises $60 Million
Warm Weather Knocks Over £500 Million Off M&S and Next
Japan's largest port hit with ransomware attack
X took two days to suspend account of suspect in Pride flag killing
China's Baidu unveils latest version of its Ernie AI model
Kinetic Business Launches All-In-One Security Solution to Protect Businesses from Cyberthreats
New King Kong game is being torn apart by the internet
The Sharrow MX™ propeller by Sharrow Marine Is a Finalist in Fast Company’s 2023 Innovation by Design Awards